Skip to main content
. 2015 Mar 27;10(3):e0122530. doi: 10.1371/journal.pone.0122530

Fig 8. 3-plex RT-qPCR for MRD detection in patients with APL treated with ATRA-based therapy after induction and 3 cycles of consolidation.

Fig 8

(A) Percentage of APL patients with PML-RARa detectable after induction and consolidation. (B) PML-RARa/ABL NCN of patients with APL after induction and consolidation. (C) MRD assessment of patients with APL after induction and consolidation. (D) Assay sensitivity of APL samples after induction and consolidation. Post consolidation 1, after the 1st cycle of consolidation; Post consolidation 2, after the 2nd cycle of consolidation; Post consolidation 3, after the 3rd cycle of consolidation.